CEN Biotech, Inc. (CENBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 5, 2025, 4:00 PM EDT
CEN Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2013 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2013 - 2016 |
| Net Income | -3.1 | -18.9 | 14.25 | -5.66 | -7.53 | -14.08 | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.46 | 0.44 | 0.44 | 0.44 | 0.43 | Upgrade
|
| Other Amortization | 0.03 | 0.11 | - | - | 0.22 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.14 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.15 | - | 1.27 | - | Upgrade
|
| Stock-Based Compensation | 0.51 | 16.62 | 1.03 | 1.21 | 0.77 | 9.37 | Upgrade
|
| Other Operating Activities | 1.44 | 0.56 | -20.22 | -0.06 | 3.04 | 2.4 | Upgrade
|
| Change in Accounts Receivable | 0.16 | 0.01 | - | -0.01 | -0.2 | -0.22 | Upgrade
|
| Change in Accounts Payable | 0.1 | 0.18 | 0.01 | -0.04 | 0.16 | -0.13 | Upgrade
|
| Change in Unearned Revenue | 0.15 | 0.15 | - | - | - | - | Upgrade
|
| Change in Income Taxes | -0.03 | 0.03 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -0.27 | 0.44 | 3.88 | 3.23 | 0.11 | 0.01 | Upgrade
|
| Operating Cash Flow | -0.59 | -0.34 | -0.34 | -0.87 | -1.72 | -2.18 | Upgrade
|
| Capital Expenditures | -0 | -0.02 | - | - | -0.01 | -0.16 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0 | - | - | - | Upgrade
|
| Cash Acquisitions | - | 0.14 | -0.11 | -0.19 | -0.1 | -0.35 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.05 | -0.11 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | - | -0.02 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.06 | 0.01 | -0.13 | -0.19 | -0.11 | -0.51 | Upgrade
|
| Short-Term Debt Issued | - | 0.05 | - | - | 0.38 | - | Upgrade
|
| Long-Term Debt Issued | - | 0.52 | 0.5 | 1.07 | 1.79 | 2.72 | Upgrade
|
| Total Debt Issued | 0.26 | 0.57 | 0.5 | 1.07 | 2.17 | 2.72 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.23 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.05 | -0.03 | -0.01 | -0.19 | -0.01 | Upgrade
|
| Total Debt Repaid | - | -0.05 | -0.03 | -0.01 | -0.42 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | 0.26 | 0.52 | 0.47 | 1.06 | 1.75 | 2.71 | Upgrade
|
| Issuance of Common Stock | 0.31 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 0.58 | 0.52 | 0.47 | 1.06 | 1.75 | 2.71 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0 | - | - | - | - | Upgrade
|
| Net Cash Flow | -0.07 | 0.19 | -0 | 0 | -0.08 | 0.02 | Upgrade
|
| Free Cash Flow | -0.59 | -0.36 | -0.34 | -0.87 | -1.73 | -2.34 | Upgrade
|
| Free Cash Flow Margin | -57.59% | -57.22% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.03 | -0.07 | -0.28 | Upgrade
|
| Cash Interest Paid | - | 0.03 | 0.08 | 0.09 | 0.07 | 0.07 | Upgrade
|
| Levered Free Cash Flow | -0.06 | 6.18 | -10.27 | 1.18 | 0.57 | 2.59 | Upgrade
|
| Unlevered Free Cash Flow | 0.13 | 6.6 | -7.97 | 3.24 | 2.37 | 4.08 | Upgrade
|
| Change in Net Working Capital | -0.13 | -0.72 | 8.05 | -3.2 | -2.88 | -1.65 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.